Built with WordPress and jQuery, hosted on WP Engine behind Cloudflare. Domain registered in 2012.
hypersomniafoundation.org is built with WordPress, hosted on WP Engine behind Cloudflare. It measures traffic with Google Analytics. It sends email through Mailchimp Transactional (Mandrill).
| Technology | Version | First seen |
|---|---|---|
| CMS & Site Builders1 | ||
| – | 17 Nov 2026 | |
| WordPress Plugins7 | ||
| 1787136745 | 17 Nov 2026 | |
| JavaScript Frameworks & Libraries2 | ||
| Frontend Build Tools & CSS3 | ||
| – | 17 Nov 2026 | |
| Web Servers, Languages & Backend Frameworks1 | ||
| – | 17 Nov 2026 | |
| CDN & Hosting2 | ||
| – | 17 Nov 2026 | |
| Analytics & Tag Management1 | ||
| – | 17 Nov 2026 | |
| Advertising & Affiliate Tracking2 | ||
| – | 17 Nov 2026 | |
| Transactional Email1 | ||
| Donations & Fundraising1 | ||
| – | 17 Nov 2026 | |
| Fonts & Icon Fonts1 | ||
| – | 17 Nov 2026 | |
| Security, WAF & Bot Protection1 | ||
| – | 17 Nov 2026 | |
Registration from the registry's RDAP record, the certificate the site serves, and its rank in public traffic lists.
The crew hasn’t read this site’s colors yet. We read a palette when we capture a site’s screenshot, busiest sites first. Meanwhile, browse palettes from other sites.
Counted from every stack change we've recorded: of the sites we watched running one of this site's tools, how many went on to add another. A pattern across sites, not a forecast for this one.
aspmx.l.google.comalt1.aspmx.l.google.comalt2.aspmx.l.google.comaspmx3.googlemail.comaspmx2.googlemail.comdns2.registrar-servers.comdns1.registrar-servers.comwpe-verification=hyperfoundprodgoogle-site-verification=1UFLZxjvypTX2smI0xsPlsXD0hAqiMlHlMAvRiXH1Bov=spf1 include:_spf.google.com include:spf.mandrillapp.com include:servers.mcsv.net ~allgoogle-site-verification=j5dAUGgjHLyxDIC7ZXNXY-Ob_JVTjRtFhmrWIdMP9pYv=DMARC1; p=none;Crawl-delay: 10 # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.hypersomniafoundation.org/sitemap_index.xml # --------------------------- # END YOAST BLOCK
# Hypersomnia Foundation > The Hypersomnia Foundation provides education, resources, and research support for people living with idiopathic hypersomnia, narcolepsy, and related sleep disorders\. Generated by Yoast SEO v28.8, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [About Us](https://www.hypersomniafoundation.org/about-us/) - [Contact us](https://www.hypersomniafoundation.org/contact-us/) - [Disclaimer](https://www.hypersomniafoundation.org/disclaimer/) - [Privacy Policy](https://www.hypersomniafoundation.org/privacy-policy/) - [What is Hypersomnia?](https://www.hypersomniafoundation.org/hypersomnia/) - [Compare symptoms of idiopathic hypersomnia and narcolepsy types 1 and 2](https://www.hypersomniafoundation.org/hypersomnia/compare/) - [Diagnosis, classification, symptoms, and causes of hypersomnias](https://www.hypersomniafoundation.org/professionals/classification/) - [Completed research studies and results](https://www.hypersomniafoundation.org/completed-research-studies/) - [International Directory of Healthcare Professionals](https://www.hypersomniafoundation.org/directory/) - [What’s it like to live with a hypersomnia?](https://www.hypersomniafoundation.org/resources/living-with-hypersomnia/) - [Treating people who have idiopathic hypersomnia or narcolepsy](https://www.hypersomniafoundation.org/professionals/treatment/) ## CM Tooltip Glossary Ecommerce - [sleep hygiene](https://www.hypersomniafoundation.org/glossary/sleep-hygiene/) - [specificity](https://www.hypersomniafoundation.org/glossary/specificity/) - [GABA\-related hypersomnia](https://www.hypersomniafoundation.org/glossary/gaba-related-hypersomnia/) - [genotype](https://www.hypersomniafoundation.org/glossary/genotype/) - [flumazenil](https://www.hypersomniafoundation.org/glossary/flumazenil/) ## Documents - [Guide: SUNY Stony Brook Career Center Information and Advice](https://www.hypersomniafoundation.org/document/guide-suny-stony-brook-career-center-information-and-advice/) - [Idiopathic Hypersomnia Severity Scale \(IHSS\)](https://www.hypersomniafoundation.org/document/idiopathic-hypersomnia-severity-scale-ihss/) - [IH Summary: Characteristics \& Diagnostic Criteria](https://www.hypersomniafoundation.org/document/ihsummary/) - [Anesthesia and Idiopathic Hypersomnia \(IH\): A Patient Guide](https://www.hypersomniafoundation.org/document/anesthesia-and-ih/) - [Hypersomnia Foundation 2022 Annual Report](https://www.hypersomniafoundation.org/document/2022-annual-report/) ## Research Studies - [DAWN Clinical Trial](https://www.hypersomniafoundation.org/research-study/dawn-clinical-trial/) - [ONSTRIDE 2: A Phase 3, Randomized, Double\-blind, Placebo\-Controlled, Efficacy and Safety Study of HBS\-301 in Participants with Idiopathic Hypersomnia Followed by an Open\-label Extension](https://www.hypersomniafoundation.org/research-study/onstride-2-a-phase-3-randomized-double-blind-placebo-controlled-efficacy-and-safety-study-of-hbs-301-in-participants-with-idiopathic-hypersomnia-followed-by-an-open-label-extension/) - [The Dynamic Light Study \- A Research Study for Narcolepsy Type 1](https://www.hypersomniafoundation.org/research-study/the-dynamic-light-study-a-research-study-for-narcolepsy-type-1/) - [The Brilliance NT1 Studies for Narcolepsy Type 1 are Now Enrolling](https://www.hypersomniafoundation.org/research-study/the-brilliance-nt1-studies-for-narcolepsy-type-1-are-now-enrolling/) - [IH \& Narcolepsy Quantitative Study Recruitment Materials](https://www.hypersomniafoundation.org/research-study/ih-narcolepsy-quantitative-study-recruitment-materials/) ## Research Study Statuses - [Completed](https://www.hypersomniafoundation.org/study-status/completed/) - [Recruiting](https://www.hypersomniafoundation.org/study-status/recruiting/) ## Optional - [Sitemap index](https://www.hypersomniafoundation.org/sitemap_index.xml)
| 3.1.19 |
| 17 Nov 2026 |
| 4.4.1 | 17 Nov 2026 |
| 3.2.2 | 17 Nov 2026 |
| – | 17 Nov 2026 |
| 11.3.0 | 17 Nov 2026 |
| 28.8 | 17 Nov 2026 |
| 3.7.1 |
| 17 Nov 2026 |
| – | 17 Nov 2026 |
| – |
| 17 Nov 2026 |
| – | 17 Nov 2026 |
| – |
| 17 Nov 2026 |
| – |
| 17 Nov 2026 |
| – |
| 17 Nov 2026 |